GHRL and neuroendocrine neoplasm: Among the known ghrelin splice variants associated with cancer, the In1-ghrelin variant, which retains intron 1 but excludes exons 3 and 4 (Figure 1), is highly expressed in several cancers, including breast, prostate, pituitary, and neuroendocrine tumors [23,24,27,28,29].